Status:
COMPLETED
Role of Ultrasound in Diagnosis of Placenta Previa and MAP
Lead Sponsor:
Aljazeera Hospital
Collaborating Sponsors:
Cairo University
National Research Centre, Egypt
Conditions:
Morbidly Adherent Placenta
Eligibility:
FEMALE
20-43 years
Brief Summary
Placenta accreta occurs when the placental implantation is abnormal. The marked rise in incidence has been assumed the increasing prevalence of cesarean delivery in recent years.
Detailed Description
The most accepted theory is that abnormal placentation . The most important risk factor for placenta accreta is placenta previa after a prior cesarean delivery. The first clinical manifestation of pla...
Eligibility Criteria
Inclusion
- pregnant ladies with previous cesarean sections
- GA above 30 weeks
Exclusion
- Primigravida patients
- GA below 30 weeks
Key Trial Info
Start Date :
March 15 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2019
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT03416296
Start Date
March 15 2018
End Date
December 20 2019
Last Update
September 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Algazeerah
Giza, Egypt